Lifeboat Foundation

Data infrastructure technology solutions from the Santa Clara, California-based company Marvell have already become an industry benchmark. Now the company has expanded its 5nm data infrastructure portfolio with a line of high-performance Prestera carrier switches and its OCTEON 10 data processing units (DPUs).

Marvell’s Prestera switches combine high-bandwidth, high-availability, and resilient switching systems with speed and high-precision synchronization benefits. In particular, the Prestera family’s optimization capability helps network operators scale with their 5G infrastructure needs. The new DX 7,321 Ethernet switch is another significant addition to the Prestera line.

Blowing older methods away, which can take hours and even days.

Global data production is estimated to reach 463 exabytes per day by 2025 — which is the equivalent of 212,765,957 DVDs per day, per the World Economic Forum.

Our existing data-storage systems, which can hold only so many 0s and 1s, and consume huge amounts of energy and space, cannot last us forever, putting us on the cusp of a serious data-storage problem that can only worsen over time. DNA-based data storage may come to the rescue as an alternative to hard drives since our genetic code is millions of times more efficient at storing information than current solutions. Now, in a breakthrough development, researchers at Northwestern University have devised a new method for recording information to DNA that takes minutes rather than hours or days.

Researchers discover previously undocumented UEFI bootkit malware used by threat actors to backdoor Windows systems since 2012.

Calcium is more abundant on WASP-76b, a hot Jupiter, than scientists expected.

“The twisted coils are the most expensive and complicated part of the stellarator and have to be manufactured to very great precision in a very complicated form,” physicist Per Helander, head of the Stellarator Theory Division at Max Planck and lead author of the new paper, told Princeton Plasma Physics Laboratory News.

The new design offers a simpler approach by instead using permanent magnets, whose magnetic field is generated by the internal structure of the material itself. As described in an article published by Nature, Zarnstorff realized that neodymium–boron permanent magnets—which behave like refrigerator magnets, only stronger—had become powerful enough to potentially help control the plasma in stellarators.

AI Art Generator App. ✅ Fast ✅ Free ✅ Easy. Create amazing artworks using artificial intelligence.

Scientists managed to arrange the electrons into a honeycomb-like lattice by sandwiching them in an electric field between two atom-thin layers of tungsten compounds, according to research published in the journal Nature last week. The ability to tame them — which scientists accomplished by exploiting the tiniest differences in the atomic structures of the two tungsten layers — marks an incredible experimental achievement that has, until now, eluded the most accomplished labs in physics.

Other researchers have claimed that they created Wigner crystals in the past, and Nature News notes that they had some convincing evidence. But no one’s actually presented imaged evidence of their crystal before, study coauthor and University of California, Berkeley physicist Feng Wang told Nature News in the physicist’s version of a microphone drop.

“If you say you have an electron crystal, show me the crystal,” he said.

Circa 2018

Inspired by the children’s TV show Transformers, engineers have developed a robot that becomes a car.

Japanese firm Brave Robotics and amusement park ride manufacturer Sansei Technologies worked together on the development.

Continue reading “Real-life Transformer: Robot becomes a car” »

AstraZeneca has requested emergency use authorization from U.S. regulators for its new treatment to prevent COVID-19 for people who respond poorly to vaccines because of a weakened immune system.

In a statement on Tuesday, the Anglo-Swedish drugmaker said it included data in its filing with the Food and Drug Administration from a late-stage trial that showed the drug reduced the risk of people developing any COVID-19 symptoms by 77 per cent.

The antibody therapy called AZD7442 could protect people who do not have a strong enough immune response to COVID-19 vaccines or to supplement a vaccination course for those, such as military personnel, who need to booster their protection further, AstraZeneca has said.

Continue reading “AstraZeneca seeks U.S. emergency approval for COVID-19 prevention drug” »